Demo

1119 Articles Matching "depression"

New Molecules Reverse Memory Loss Linked To Depression, Aging

Feb 16, 2019 , NewsLine - Healthcare Professionals
New therapeutic molecules developed at Toronto's Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging. These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing m......
Read more

Ambivalence Over Motherhood Could Reshape Practices Around Family Planning

Feb 16, 2019 , Kaiser Health News
New data from a CDC survey finds that in up to 19 percent of pregnancies, women are unsure if they want to be pregnant, a state of mind doctors need to be in tune with when counseling them, researchers say. Public health news looks at AIDS death rates in the South; depression's harmful role in aging brains; looking for treatments in moss piglets and a reason to get off the couch this weekend, as...
Read more

Teen Pot Use Linked to Later Depression, Suicide Attempts

Feb 16, 2019 , MedicineNet
Title: Teen Pot Use Linked to Later Depression, Suicide AttemptsCategory: Health NewsCreated: 2/13/2019 12:00:00 AMLast Editorial Review: 2/14/2019 12:00:00...
Read more

FDA Panel Backs Ketamine-like Drug for Depression

Feb 16, 2019 , MedicineNet
Title: FDA Panel Backs Ketamine-like Drug for DepressionCategory: Health NewsCreated: 2/14/2019 12:00:00 AMLast Editorial Review: 2/14/2019 12:00:00...
Read more

Counseling Can Prevent Pregnancy-Related Depression: Task Force

Feb 15, 2019 , MedicineNet
Title: Counseling Can Prevent Pregnancy-Related Depression: Task ForceCategory: Health NewsCreated: 2/13/2019 12:00:00 AMLast Editorial Review: 2/13/2019 12:00:00...
Read more
Banner Health Children

FDA Panel Backs Ketamine-like Drug for Depression

Feb 14, 2019 , WebMD
Despite the panel's approval, two of five key studies of esketamine failed to meet their primary goals. When taking esketamine, some patients experienced sedation, blood pressure spikes and dissociation (feeling disconnected from surroundings) within two hours of taking the drug, CNN...
Read more

Janssen’s nasal spray for depression clears FDA committee

Feb 14, 2019 , Drug Store News - Retail
If approved, Spravato will offer the first new mechanism of action in 30 years to treat adults with treatment-resistant depression. Read More...
Read more

Does PTSD Really Harm Veterans' Hearts?

Feb 14, 2019 , WebMD
Veterans with PTSD had higher rates of smoking, depression, anxiety disorders, sleep disorders, type 2 diabetes, obesity, high blood pressure and high cholesterol, but no single condition explained the association between PTSD and heart disease, a new study...
Read more

Teen cannabis use linked to higher risk of adolescent depression

Feb 14, 2019 , Reuters
Teenagers who use cannabis have a higher risk of developing depression and suicidal thoughts as young adults and should be made aware of those risks by parents and doctors, scientists said on Wednesday....
Read more

Wellbutrin vs. Prozac

Feb 14, 2019 , RxList
Wellbutrin (bupropion) and Prozac (fluoxetine) are antidepressants used to manage major...
Read more

Teen Pot Use Raises Later Suicide Risk

Feb 14, 2019 , WebMD
Not only were those who smoked marijuana more likely to suffer depression and suicidal thoughts, they were also more than three times as likely to attempt suicide between the ages of 18 and...
Read more
Demo

Johnson & Johnson's nasal spray for depression wins FDA panel backing

Feb 13, 2019 , Reuters
An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval....
Read more

Another Winter Storm Is Coming. Here's How It Can Affect Your Mental Health.

Feb 13, 2019 , Forbes
Extreme heat has been linked to higher rates of suicide and even violent crime, while cold weather can worsen...
Read more

Ketamine-like depression treatment on track for FDA approval

Feb 13, 2019 , CNN Health
A ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved by the FDA, the drug -- called esketamine -- may provide a new option for patients with major depressive disorder who have tried at least two other antidepressants without success....
Read more

Nearly 8 million US Kids Have Mental Issues

Feb 13, 2019 , WebMD
Mental health problems in U.S. children are common, according to a new survey, with about 1 in 6 children of school age affected. The survey asked parents about anxiety, depression and attention deficit/hyperactivity disorder or ADHD—because they are the most prevalent and pose the greatest risk for long-term...
Read more

Evidence Emerges That Promising Flu Killer Drug Doesn’t Work Well For Some Patients

Feb 12, 2019 , Kaiser Health News
A mutant viral strain can stop the anti-flu medication Xofluza from working. Other public health news reported over the weekend covers depression, mental health struggles, gene-edited babies, anti-aging research, medication dosages for kids, hospital toxic waste, multiple sclerosis and...
Read more

Many Different Diets Can Improve Mood And Reduce Depression Symptoms, Study Finds

Feb 11, 2019 , Forbes
A new study shows that no single dietary approach has a monopoly on improving...
Read more

Study: Social Media Not A Teen Depression Trigger

Feb 09, 2019 , WebMD
Social media use did not predict the development of depression symptoms among school kids or college students, researchers...
Read more

Mayo Clinic teams up with Leidos to build accelerator, Save the Children taps EarlySense for pilot program and other digital health deals

Feb 08, 2019 laura.lovett@himssmedia.com (Laura Lovett), Mobile Health News
Also: Bright.md worked with Ozers and providers from Kaiser Permanente on anxiety and depression platform; MobileSmith Health teams up with Isabel Healthcare on pediatrics...
Read more

Mouse Studies Advance Search For New Class Of Antidepressants

Feb 08, 2019 , NewsLine - Healthcare Professionals
In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression. A compound developed by the Johns Hopkins Drug Discovery Group targets a chemical in specific cells of the mammalian brain, and eases signs of ......
Read more